INTS vs XRAY
Intensity Therapeutics, Inc. Common stock (INTS) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2024-12-31 was $3.79B. Net income was -$910.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. XRAY currently screens at market cap $2.01B.
INTS currently screens at market cap $7.7M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the INTS and XRAY stock pages for the full models.
Not investment advice.